Assessment of pexelizumab in acute myocardial infarction (APEX AMI): A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention
Publication
, Conference
Armstrong, PW; Adams, PX; Hamm, CW; O'Neill, WW; Vahanian, AS; Granger, CB; Holmes, DR; Todaro, TG; Van de Werf, F
Published in: CIRCULATION
November 28, 2006
Duke Scholars
Published In
CIRCULATION
ISSN
0009-7322
Publication Date
November 28, 2006
Volume
114
Issue
22
Start / End Page
2425 / 2425
Location
Chicago, IL
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Conference Name
79th Annual Scientific Session of the American-Heart-Association
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Armstrong, P. W., Adams, P. X., Hamm, C. W., O’Neill, W. W., Vahanian, A. S., Granger, C. B., … Van de Werf, F. (2006). Assessment of pexelizumab in acute myocardial infarction (APEX AMI): A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. In CIRCULATION (Vol. 114, pp. 2425–2425). Chicago, IL: LIPPINCOTT WILLIAMS & WILKINS.
Armstrong, Paul W., Peter X. Adams, Christian W. Hamm, William W. O’Neill, Alec S. Vahanian, Christopher B. Granger, David R. Holmes, Thomas G. Todaro, and Frans Van de Werf. “Assessment of pexelizumab in acute myocardial infarction (APEX AMI): A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.” In CIRCULATION, 114:2425–2425. LIPPINCOTT WILLIAMS & WILKINS, 2006.
Armstrong PW, Adams PX, Hamm CW, O’Neill WW, Vahanian AS, Granger CB, et al. Assessment of pexelizumab in acute myocardial infarction (APEX AMI): A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. In: CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2006. p. 2425–2425.
Armstrong, Paul W., et al. “Assessment of pexelizumab in acute myocardial infarction (APEX AMI): A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.” CIRCULATION, vol. 114, no. 22, LIPPINCOTT WILLIAMS & WILKINS, 2006, pp. 2425–2425.
Armstrong PW, Adams PX, Hamm CW, O’Neill WW, Vahanian AS, Granger CB, Holmes DR, Todaro TG, Van de Werf F. Assessment of pexelizumab in acute myocardial infarction (APEX AMI): A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2006. p. 2425–2425.
Published In
CIRCULATION
ISSN
0009-7322
Publication Date
November 28, 2006
Volume
114
Issue
22
Start / End Page
2425 / 2425
Location
Chicago, IL
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Conference Name
79th Annual Scientific Session of the American-Heart-Association
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology